Analysis10k / Blog
EN한국어ES

#Pharmaceuticals

7 articles tagged "Pharmaceuticals".

LLY
Company Snapshot

Eli Lilly (LLY): What This Company Actually Does

A plain-English read of Eli Lilly's business model, built directly from its SEC filings — no hype, just where the money comes from.

2026-09-28
LLY
The Story

Eli Lilly's Last Three Years: A Company That Couldn't Keep Up With Its Own Success

How Mounjaro and Zepbound demand kept outrunning Eli Lilly's own guidance — and how the two moments that looked like trouble both turned into launching pads for the next raise.

2026-09-28
ABBV
Company Snapshot

AbbVie (ABBV): What This Company Actually Does

A plain-English read of AbbVie's business model, built directly from its SEC filings — no hype, just where the money comes from.

2026-09-27
ABBV
The Story

AbbVie's Last Three Years: 'Raising Guidance' While the Number Keeps Falling

How a CEO transition and a buying spree turned AbbVie's own guidance language into a puzzle worth decoding every quarter.

2026-09-27
PFE
Company Snapshot

Pfizer (PFE): What This Company Actually Does

A plain-English read of Pfizer's business — patented drugs and vaccines sold through a handful of wholesalers, paid for mostly by governments and insurers, not patients — built directly from its SEC filings.

2026-09-19
PFE
The Story

Pfizer's Story: A Guidance Cut, a Comeback, Then Two Shocks at Once

Pfizer slashed its own 2023 guidance in half and lost credibility, clawed it back with a conservative 2024 target it beat by a wide margin, then got hit by a failed obesity drug and a tariff shock in the same spring.

2026-09-19
MRK
Company Snapshot

Merck (MRK): What This Company Actually Does

A plain-English read of Merck's business — the cancer immunotherapy Keytruda that alone drives nearly half of company revenue, plus vaccines and animal health — built directly from its SEC filings.

2026-09-12